The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bluemedical.com

Founded Year

1998

Stage

Acquired | Acquired

Total Raised

$240K

About Blue Medical

Provider of cardiovascular devices. The company provides a range of coronary stent delivery systems, including coated coronary stents and small and large vessel coronary stent delivery systems, rapid exchange PTCA catheters, femoral closure devices, and other cardiovascular devices.[Keywords: angioplasty, biocompatible]

Blue Medical Headquarter Location

Steenovenweg 19

Helmond, 5708 HN,

Netherlands

31 492 588 900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Blue Medical Patents

Blue Medical has filed 2 patents.

The 3 most popular patent topics include:

  • Anesthesia
  • Emergency medical procedures
  • Intensive care medicine
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/3/2019

Anesthesia, Medical equipment, Intensive care medicine, Respiratory therapy, Emergency medical procedures

Application

Application Date

7/3/2019

Grant Date

Title

Related Topics

Anesthesia, Medical equipment, Intensive care medicine, Respiratory therapy, Emergency medical procedures

Status

Application

Latest Blue Medical News

Deep Blue Medical Advances lures $3.44M in equity for hernia repair tech

Feb 5, 2021

DURHAM — Deep Blue Medical Advances , which received FDA clearance to begin selling its hernia mesh product in August 2020, has increased its equity to $3.44 million, according to a regulatory filing. The company raised $1.57 million in debt in January. The company disclosed both raises in filings with the U.S. Securities and Exchange Commission. The company says its T-Line Hernia Mesh “provides superior anchoring strength and eliminates a key point of failure for conventional mesh fixation.” It is designed to counter “mesh migration, contraction and eventual failure. Deep Blue previously raised more than $800,000 in funding. The company was founded in 2014 by Duke plastic surgeon Howard Levinson, MD. In separate efforts, Levinson is working on additional  projects including an anti-biofouling Foley catheter, a non-invasive light imaging technology to diagnose skin disorders, and tissue-engineered skin that resists contraction. “Sewing a bit of each extension into the abdominal wall, in lieu of traditional sutures, significantly increases mesh anchoring strength and thus the durability of the repair,” Levinson says of the T-Line. “We believe this approach will greatly improve patient outcomes without necessitating significant changes to current surgical practice.” Millions of hernia surgeries are done globally at billions in clinical costs and support a $1.1 billion hernia device market.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.